Responsable(s)
Directrice-adjointe - Le responsable ne souhaite pas publier ses coordonnées.
Directeur - Olivier DELATTRE à partir du 01/01/2009 ( olivier.delattre@curie.fr )
|
|
Etablissements. |
|
INS.CURIE - Institut Curie Paris (U 830)
(établissement tutelle à
partir de 2009)
Etablissement référent
|
|
INSERM - Institut national de la sante et de la recherche medicale (U 830)
(établissement tutelle à
partir de 2009)
|
|
PSL - Université Paris sciences et lettres (U 830)
(établissement tutelle à
partir de 2020)
|
Adresse Institut Curie, Centre de Recherche, 26, rue d'Ulm
75248 PARIS
|
Contact
courriel : carole.drique@curie.fr
|
Site web :
https://curie.fr/unite/u830
|
Taille en ETP (sans compter les stagiaires):
entre 10 et 50.
|
Descriptif :
The unit is interested in several aspects of cancer research. Cancer genetics and epigenetics are more specifically developed on breast and ovarian cancers, melanomas and paediatric cancers (like Ewing sarcoma
and neuroblastoma). The original genetic program is now extended to studies of genetic instability and replication stress, in addition two other cancer-related topics are investigated; i.e. tumor microenvironment with the characterization of CAF sub-populations and tumor metabolism. These research axes are interconnected, inter alia, through translational research programs. The unit presented these last years a remarkable continuum from top level basic to translational research.
|
Année de création :
2009
|
Mission de la structure :
Recherche
|
Mode de gestion de la structure :
Gestion au cas par cas
|
SIRET de la structure :
78425716400045
|
Classement scientifique ERC
- LS2 : Integrative Biology: from Genes and Genomes to Systems : Genetics, epigenetics, genomics and other ‘omics studies, bioinformatics, systems biology, genetic diseases, gene editing, innovative methods and modelling, ‘omics for personalised medicine
- LS7 : Prevention, Diagnosis and Treatment of Human Diseases : Medical technologies and tools for prevention, diagnosis and treatment of human diseases, therapeutic approaches and interventions, pharmacology, preventative medicine, epidemiology and public health, digital medicine
- LS4 : Physiology in Health, Disease and Ageing : Organ and tissue physiology, comparative physiology, physiology of ageing, pathophysiology, inter-organ and tissue communication, endocrinology, nutrition, metabolism, interaction with the microbiome, non-communicable diseases including cancer (and except disorders of the nervous system and immunity-related diseases))
|
Domaine scientifique
- 5 : Biologie, médecine et santé 2009 0
|
Ecole(s) doctorale(s) de rattachement
Non renseigné
|
Rattachée au(x) programme(s) LOLF suivant(s):
Non renseigné
|
Rattachée au(x) thème(s) de recherche suivant(s):
Genetic; Epignetic; Signaling; oxidative stress; stroma; tumor micro-environment; miR-200; breast and ovarian cancers; DNA repair; BRCAness; HRD; CDK12; Genomic instability; SF3B1;
pediatric cancers; translational research; molecular characterisation; models; new treatment strategies;
|
Liens avec d'autres structures :
Aucun.
|
Site ESR :
Aucun.
|
Fiche mise à jour par Tatiana MALHERBE le 22/08/2023 à 17:47
|